Tumor-associated neutrophils in breast cancer: an angel or a devil?

Breast cancer is the most common malignant tumor in women, ranking first globally in both incidence and mortality rates among female malignancies, posing a severe threat to women’s physical and mental health. Neutrophils are recognized as the first line of host defense against pathogens and exert be...

Full description

Saved in:
Bibliographic Details
Main Authors: Siyuan Wen, Tianli Feng, Yu Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593156/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331979663704064
author Siyuan Wen
Tianli Feng
Yu Fan
author_facet Siyuan Wen
Tianli Feng
Yu Fan
author_sort Siyuan Wen
collection DOAJ
description Breast cancer is the most common malignant tumor in women, ranking first globally in both incidence and mortality rates among female malignancies, posing a severe threat to women’s physical and mental health. Neutrophils are recognized as the first line of host defense against pathogens and exert beneficial effects in the body. However, emerging evidence has demonstrated that tumor-associated neutrophils (TANs) exhibit a dual role in breast cancer progression and prognosis. Therefore, elucidating their molecular mechanisms may provide novel insights for targeted therapies, potentially improving clinical outcomes for breast cancer patients. This review summarizes the interplay between TANs and breast cancer, their underlying mechanisms, and their potential as immunotherapeutic targets.
format Article
id doaj-art-6a2d1e0c8619467d8001b10a6cd76fd9
institution Kabale University
issn 1664-3224
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-6a2d1e0c8619467d8001b10a6cd76fd92025-08-20T03:46:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.15931561593156Tumor-associated neutrophils in breast cancer: an angel or a devil?Siyuan Wen0Tianli Feng1Yu Fan2Faculty of Clinical Medicine, Southwest Medical University, Luzhou, ChinaFaculty of Clinical Medicine, Southwest Medical University, Luzhou, ChinaDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaBreast cancer is the most common malignant tumor in women, ranking first globally in both incidence and mortality rates among female malignancies, posing a severe threat to women’s physical and mental health. Neutrophils are recognized as the first line of host defense against pathogens and exert beneficial effects in the body. However, emerging evidence has demonstrated that tumor-associated neutrophils (TANs) exhibit a dual role in breast cancer progression and prognosis. Therefore, elucidating their molecular mechanisms may provide novel insights for targeted therapies, potentially improving clinical outcomes for breast cancer patients. This review summarizes the interplay between TANs and breast cancer, their underlying mechanisms, and their potential as immunotherapeutic targets.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593156/fullbreast cancertumor-associated neutrophilsimmune cellimmune microenvironmenttargeted therapy
spellingShingle Siyuan Wen
Tianli Feng
Yu Fan
Tumor-associated neutrophils in breast cancer: an angel or a devil?
Frontiers in Immunology
breast cancer
tumor-associated neutrophils
immune cell
immune microenvironment
targeted therapy
title Tumor-associated neutrophils in breast cancer: an angel or a devil?
title_full Tumor-associated neutrophils in breast cancer: an angel or a devil?
title_fullStr Tumor-associated neutrophils in breast cancer: an angel or a devil?
title_full_unstemmed Tumor-associated neutrophils in breast cancer: an angel or a devil?
title_short Tumor-associated neutrophils in breast cancer: an angel or a devil?
title_sort tumor associated neutrophils in breast cancer an angel or a devil
topic breast cancer
tumor-associated neutrophils
immune cell
immune microenvironment
targeted therapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593156/full
work_keys_str_mv AT siyuanwen tumorassociatedneutrophilsinbreastcanceranangeloradevil
AT tianlifeng tumorassociatedneutrophilsinbreastcanceranangeloradevil
AT yufan tumorassociatedneutrophilsinbreastcanceranangeloradevil